Intermittent multidrug IV therapy potentially useful in refractory Mycobacterium abscessus pulmonary disease
In a small study of 36 patients in South Korea, 62% and 12% of those with M. abscessus disease and 80% and 60% of those with M. massiliense disease had at least one negative culture and culture conversion, respectively.
13 Sep 2023
Only a third of the patients were discharged on anticoagulation, and over a three-year follow-up period, receiving anticoagulation was not associated with a significant reduction in ischemic stroke.
4 Oct 2017
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
A Spanish trial found that using d-dimer testing and, if positive, a CT pulmonary angiogram to diagnose pulmonary embolism (PE) did not affect risk of death, clot, or readmission in patients hospitalized for exacerbation of chronic obstructive pulmonary disease (COPD).
20 Oct 2021
Although the optimal use of procalcitonin is still up for debate, there are best practices for getting the most bang for this blood test.
5 Jul 2023
Only 1.5% of studied patients began pulmonary rehabilitation within 90 days of discharge from a hospitalization for chronic obstructive pulmonary disease (COPD), but their rate of readmission within a year was 56.4%, compared to 64.6% in patients who did not begin rehab.
28 Jul 2021
Review some common inpatient conditions that can be safely treated with shorter durations of antibiotics, reducing adverse events and costs.
17 May 2023
A group of cases involving lytic lesions.
9 Aug 2023
Treatment failure was less common among hospitalized patients with chronic obstructive pulmonary disease (COPD) who received personalized corticosteroid therapy, guided by a dosing scale, than in those who received a 40-mg/d fixed dose of prednisolone or the equivalent, a Chinese study found.
26 May 2021
Patients with an exacerbation of chronic obstructive pulmonary disease (COPD) that was severe according to the recently proposed Rome criteria had about twice the risk of death within a year as those whose exacerbation was mild, a retrospective study found.
2 Aug 2023